
Ocular symptoms in COVID-19 patients may be more common than previously thought — with sore eyes a significant sign of disease.
Ocular symptoms in COVID-19 patients may be more common than previously thought — with sore eyes a significant sign of disease.
Spaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
A novel ocular corticosteroid is offering hope of quick results for patients.
Preeya Gupta, MD, discusses the results of a study evaluating the safety and efficacy of KPI-121 0.25% for the treatment of dry eye disease.
Improvements gained prior to surgery can result in positive outcomes.
Protocol T Extension Study details methods needed to maintain VA gains over time.
Ehsan Rahimy, MD, speaks on the highlights of a study he presented at this year's virtual AAO 2020 meeting that aimed to integrate an artificial intelligence screening system for managing diabetic retinopathy referrals in a primary care setting — with limited specialty support.
Programs use detection and treatment to ease burden of eye disease.
DME diagnosis plays no role in determining whether patients will receive injection.
New paradigm-changing treatments for young patients on the horizon.
Investigators research safety, efficacy of endolaserless vitrectomy.
Using active learning approach can help gauge visual function loss in patients
Researchers evaluate effects of procedure on patients with abnormal topography
Watchful waiting may prove to be beneficial in complicated cases
Investigators have found that the diameter of retinal veins may be linked directly to the severity of COVID-19. Assessing the retinal veins may be a part of diagnosing and managing the disease.
Fast-acting efficacious options are key to treating acute inflammation
Cynthia Matossian, MD, FACS, explains why she believes if ophthalmologists consistently evaluate the ocular surface, tear film and lid margins—and treat any problems that we find—surgical outcomes will improve.
It's not always easy to convince early-stage, minimally symptomatic or symptomatic patients that their MGD should be treated. Cynthia Matossian, MD, FACS, explains why ophthalmologists shouldn't take this personally and how not to accept their denial as a final answer.
Evidence-based medicine can lead to personalized care, better results for patients
Relational thickness altered tool details LASIK impact on the cornea.
Study results give ophthalmologists a plan for treating patients with good vision.
Research results can help ophthalmologists treating patients with macular edema
Investigators examine and analyze outcomes of aflibercept compared with laser treatment in patients
Gene therapy to treat choroideremia shows potential for maintaining or improving vision
Machine-learning algorithms have potential to predict patients with nonproliferative diabetic retinopathy who will or will not improve over time.